z-logo
Premium
Highly Enantioselective Hydrogenation of Ethyl 5,5‐Dimethoxy‐3‐oxopentanoate and its Application for the Synthesis of a Statin Precursor
Author(s) -
Korostylev Andrei,
Andrushko Vasyl,
Andrushko Natalia,
Tararov Vitali I.,
König Gerd,
Börner Armin
Publication year - 2008
Publication title -
european journal of organic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 155
eISSN - 1099-0690
pISSN - 1434-193X
DOI - 10.1002/ejoc.200701059
Subject(s) - chemistry , enantioselective synthesis , asymmetric hydrogenation , catalysis , rosuvastatin , alcohol , noyori asymmetric hydrogenation , homogeneous , substrate (aquarium) , homogeneous catalysis , combinatorial chemistry , stereochemistry , medicinal chemistry , organic chemistry , medicine , physics , oceanography , geology , thermodynamics
The highly enantioselective hydrogenation of ethyl 5,5‐dimethoxy‐3‐oxopentanoate ( 3 ) to ethyl 3‐hydroxy‐5,5‐dimethoxypentanoate ( 4 ) – a key intermediate in the synthesis of pharmacologically important statin drugs – has been investigated. The stereochemistry of the catalytic hydrogenation of the β‐keto ester in the presence of a number of homogeneous chiral Rh I and Ru II complexes with phosphane ligands has been studied. The highest enantioselectivity for the homogeneous hydrogenation of 3 (up to 98.7 % ee ) was achieved through an optimized version of Genêt's procedure with a Ru[( R )‐BINAP]Cl 2 pre‐catalyst (substrate/catalyst ratio up to 20 000:1, 50 bar H 2 , 50 °C, in MeOH). The transformation of alcohol R ‐( 4 ) into ylide R ‐( 6 ) as an important precursor of the chiral side chain of rosuvastatin is also illustrated. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom